Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84K Sell
33
-4
-11% -$259 ﹤0.01% 1545
2025
Q4
$2.31K Buy
37
+4
+12% +$238 ﹤0.01% 964
2025
Q3
$1.91K Hold
33
﹤0.01% 1013
2025
Q2
$1.63K Hold
33
﹤0.01% 1021
2025
Q1
$1.46K Hold
33
﹤0.01% 1046
2024
Q4
$1.55K Hold
33
﹤0.01% 1030
2024
Q3
$1.55K Hold
33
﹤0.01% 1009
2024
Q2
$1.25K Hold
33
﹤0.01% 1034
2024
Q1
$1.23K Hold
33
﹤0.01% 984
2023
Q4
$1.09K Buy
+33
New +$1.07K ﹤0.01% 978

Other funds holding GIL

CVA Family Office's GIL Position: Q1 2026 in Review

CVA Family Office reduced its Gildan (GIL) stake by 11% in Q1 2026, selling an estimated $259 and leaving 33 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

CVA Family Office first reported a position in GIL in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.31K in Q4 2025. 482 funds tracked by Wall St. Rank hold GIL as of Q1 2026.

  • CVA Family Office held 33 shares of Gildan worth $1.84K as of Q1 2026.
  • CVA Family Office sold 4 Gildan shares in Q1 2026, an estimated $259.
  • Gildan made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1545 holding.
  • CVA Family Office first reported a position in Gildan in Q4 2023 and has held it in 10 quarters since.
  • CVA Family Office's Gildan position peaked at $2.31K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Gildan as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.